Betge, Johannes <br/><br/>
Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative.  [electronic resource] 

 -  Digestion  2016 
 - 129-137 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1421-9867 
<br/><br/><label>Standard No.: </label>10.1159/000449412  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab--therapeutic use<br/>Clinical Trials, Phase II as Topic<br/>Colorectal Neoplasms--diagnostic imaging<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Pyrimidines--therapeutic use<br/>Retrospective Studies<br/>Survival Rate<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Ultrasonography